Ellen Chiniara Alexion Pharmaceuticals, Inc. (ALXN) insider trading activity

Ellen Chiniara is EVP & Chief Legal Officer of ALEXION PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ALXN, which is worth approximately $0. The most recent transaction as insider was on Jul 21, 2021, when has been sold 116,850 shares (Common Stock, par value $.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Ellen Chiniara Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 21 2021	SELL Sale (or disposition) back to the issuer	-	116,850 Reduced 100.0%	0 Common Stock, par valu...
Jul 14 2021	BUY Grant, award, or other acquisition	-	54,469 Added 31.79%	116,850 Common Stock, par valu...
Feb 28 2021	BUY Grant, award, or other acquisition	-	19,321 Added 23.65%	62,381 Common Stock, par valu...
Dec 16 2020	SELL Payment of exercise price or tax liability	$3,145,458 $157.96 p/Share	19,913 Reduced 31.65%	43,004 Common Stock, par valu...
Dec 16 2020	BUY Grant, award, or other acquisition	-	37,965 Added 37.63%	62,917 Common Stock, par valu...
Dec 15 2020	BUY Grant, award, or other acquisition	$5,350 $95.53 p/Share	56 Added 0.13%	43,060 Common Stock, par valu...

Also insider at

CMPX

Compass Therapeutics, Inc. Healthcare

Director

KYMR

Kymera Therapeutics, Inc. Healthcare

Chief Legal Officer

Ellen Chiniara

EVP & Chief Legal Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALXN shares.

Notify only if

Value

Insider Trading

Get notified when an Alexion Pharmaceuticals, Inc. insider buys or sells ALXN shares.

Notify only if

Operation

Value

Type

News

Receive news related to ALEXION PHARMACEUTICALS, INC.

Track Activities on ALXN

Account